Equities Research Analysts’ updated eps estimates for Thursday, December 6th:
Aclaris Therapeutics (NASDAQ:ACRS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania. “
Aldeyra Therapeutics (NASDAQ:ALDX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Aldeyra Therapeutics, Inc. is a biotechnology company. The company’s products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts. “
Alpha and Omega Semiconductor (NASDAQ:AOSL) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Alpha and Omega Semiconductor Limited is engaged in designing, developing and supplying a broad range of power semiconductors globally, including a portfolio of Power MOSFET and Power IC products. The Company seeks to differentiate itself by integrating its expertise in device physics, process technology, design and advanced packaging to optimize product performance and cost. Its portfolio of products targets high-volume end-market applications, such as notebooks, netbooks, flat panel displays, mobile phone battery packs, set-top boxes, portable media players and power supplies. The products are incorporated into devices by original equipment manufacturers, or OEMs. The Company utilizes third-party foundries for all of its wafer fabrication and it deploys and implements its proprietary MOSFET processes at these third party foundries. The Company relies upon its in-house capacity and an associated provider for most of its packaging and testing requirements. “
AISIN SEIKI CO/ADR (OTCMKTS:ASEKY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Aisin Seiki Co., Ltd. is engages in the manufacture and sale of automotive parts. It operating segment consists of Aisin Seiki Group, Aisin Takaoka Group, Aisin AW Group, Advics Group and Others. Aisin Seiki Group segment provides general automotive parts and services, life and amenity-related equipment, public works and petroleum sales. Aisin Takaoka Group segment handles engine and brake cast components. Aisin AW Group deals with automatic transmissions and car navigation systems. Advics Group segment offers brake components. Others segment includes automotive parts lineup, energy systems, mainstay products for the major group companies, life and amenity products. Aisin Seiki Co., Ltd. is headquartered in Kariya, Japan. “
Aroundtown (ETR:AT1) was given a €9.60 ($11.16) target price by analysts at Goldman Sachs Group Inc. The firm currently has a buy rating on the stock.
Advantest (OTCMKTS:ATEYY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $24.00 price target on the stock. According to Zacks, “Advantest Corporation is one of the world’s leading automatic test equipment suppliers to the semiconductor industry, and is also a producer of electronic and optoelectronic instruments and systems. A global company, Advantest has long offered total ATE solutions, and serves the industry in every component of semiconductor test: tester, handler, mechanical and electrical interfaces, and software. Its logic, memory, mixed-signal and RF testers, and device handlers, are integrated into the most advanced semiconductor fabrication lines in the world. “
GRUPO AVAL ACCI/S (NYSE:AVAL) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Grupo Aval Acciones y Valores S.A. is a financial services group. It provides a comprehensive range of financial services and products ranging from traditional banking services, such as making loans and taking deposits, to pension and severance fund management. The company also provides general purpose loans, foreign exchange services, documentation services, guarantees, auto financing, payroll loans, and credit cards, as well as various deposit and basic treasury products. It provides fiduciary services; merchandise storage and deposit, customs agency, cargo management, and merchandise distribution; brokerage services, fund management, portfolio management, securities management, and capital markets consulting services; and investment banking, treasury, and private banking services. Grupo Aval Acciones Y Valores S.A. is based in Bogotá, Colombia. “
AXT (NASDAQ:AXTI) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “AXT, Inc., designs, develops, manufactures and distributes high-performance compound semiconductor substrates, as well as opto-electronic semiconductor devices such as high-brightness light emitting devices, and vertical cavity surface emitting lasers. “
Saul Centers (NYSE:BFS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “SAUL CENTERS, INC. is a real estate investment trust which is engaged in the management and development of the shopping center business of the Saul Organization. “
Bayerische Motoren Werke (ETR:BMW) was given a €70.00 ($81.40) price target by analysts at Commerzbank AG. The firm currently has a sell rating on the stock.
easyJet (LON:EZJ) was given a GBX 1,600 ($20.91) target price by analysts at Royal Bank of Canada. The firm currently has a buy rating on the stock.
Korea Electric Power (NYSE:KEP) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating.
Childrens Place (NASDAQ:PLCE) had its price target trimmed by Wolfe Research from $169.00 to $135.00. They currently have a peer perform rating on the stock.
Receive News & Ratings for Aclaris Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclaris Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.